Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperlipidemia and Mixed Dyslipidemia”

99 trials

Showing 20 of 99 results

Post-approval studies (Phase 4)UnknownNCT01010516
What this trial is testing

Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia

Who this might be right for
Dyslipidemia
University of Ioannina 120
Not applicableUnknownNCT01974297
What this trial is testing

Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid

Who this might be right for
Mixed Hyperlipidemia
Sang Hak Lee 194
Large-scale testing (Phase 3)Study completedNCT00465088
What this trial is testing

An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)

Who this might be right for
HyperlipidemiaMixed Dyslipidemia
Abbott 199
Large-scale testing (Phase 3)Study completedNCT00136799
What this trial is testing

Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia

Who this might be right for
Mixed DyslipidemiaHypercholesterolemia
Novartis 325
Large-scale testing (Phase 3)Looking for participantsNCT07421297
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

Who this might be right for
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 760
Large-scale testing (Phase 3)Ended earlyNCT01274559
What this trial is testing

Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,173
Large-scale testing (Phase 3)Study completedNCT05255094
What this trial is testing

Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 464
Large-scale testing (Phase 3)Not Yet RecruitingNCT07441317
What this trial is testing

QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 780
Testing effectiveness (Phase 2)Study completedNCT07278830
What this trial is testing

A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Hypercholesterolemia and Mixed Dyslipidemia
Shenzhen Salubris Pharmaceuticals Co., Ltd. 214
Large-scale testing (Phase 3)Study completedNCT05532800
What this trial is testing

The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hyperlipemia
Shanghai Junshi Bioscience Co., Ltd. 255
Large-scale testing (Phase 3)Study completedNCT04849000
What this trial is testing

Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipemia
Jiangsu HengRui Medicine Co., Ltd. 709
Large-scale testing (Phase 3)Study completedNCT00536510
What this trial is testing

Effect of MK0524A on Cholesterol Levels (0524A-048)

Who this might be right for
HypercholesterolemiaHyperlipidemia
Merck Sharp & Dohme LLC 646
Large-scale testing (Phase 3)Study completedNCT02833844
What this trial is testing

Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

Who this might be right for
Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection
Amgen 467
Large-scale testing (Phase 3)Study completedNCT00376584
What this trial is testing

Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)

Who this might be right for
HypercholesteremiaHyperlipidemia
Merck Sharp & Dohme LLC 825
Large-scale testing (Phase 3)Study completedNCT00289900
What this trial is testing

Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)

Who this might be right for
Mixed Hyperlipidemia
Merck Sharp & Dohme LLC 2,340
Large-scale testing (Phase 3)Study completedNCT01420549
What this trial is testing

Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia

Who this might be right for
HypercholesterolemiaDyslipidemia
Ache Laboratorios Farmaceuticos S.A. 129
Large-scale testing (Phase 3)Study completedNCT00378833
What this trial is testing

Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)

Who this might be right for
HypercholesterolemiaHyperlipidemia
Merck Sharp & Dohme LLC 1,300
Large-scale testing (Phase 3)Study completedNCT01763866
What this trial is testing

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

Who this might be right for
Hyperlipidemia
Amgen 2,067
Testing effectiveness (Phase 2)Study completedNCT07421232
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 156
Large-scale testing (Phase 3)Study completedNCT02739984
What this trial is testing

Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia

Who this might be right for
HypercholesterolemiaMixed DyslipidemiaType 2 Diabetes
Amgen 424
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation